Cargando…
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials
INTRODUCTION: Safety underreporting is a recurrent issue in clinical trials that can impact patient safety and data integrity. Clinical quality assurance (QA) practices used to detect underreporting rely on on-site audits; however, adverse events (AEs) underreporting remains a recurrent issue. In a...
Autores principales: | Barmaz, Yves, Ménard, Timothé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278191/ https://www.ncbi.nlm.nih.gov/pubmed/34260043 http://dx.doi.org/10.1007/s40264-021-01094-8 |
Ejemplares similares
-
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning
por: Ménard, Timothé, et al.
Publicado: (2019) -
Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
por: Ménard, Timothé, et al.
Publicado: (2019) -
Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?
por: Koneswarakantha, Björn, et al.
Publicado: (2020) -
Using Statistical Modeling for Enhanced and Flexible Pharmacovigilance Audit Risk Assessment and Planning
por: Zou, Min, et al.
Publicado: (2020) -
Modelling underreported spatio-temporal crime events
por: Riascos Villegas, Álvaro J., et al.
Publicado: (2023)